FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and pharmaceutics and deals with application of 3-methyl-6-(1-methylethenyl)cyclohex-3-ene-1,2-diol, its isomers and derivatives as medication for treatment of Parkinson's disease.
EFFECT: medication possesses high activity, low toxicity and can be obtained from available natural compound of a-pinene.
7 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1,2-DIOL- EPOXIDES - NEW ANTIPARKINSONIAN DRUGS AND ANTI-CONVULSANTS | 2014 |
|
RU2571299C1 |
| 2-((1-(4R-BENZYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)-3-METHYL-6-(PROP-1-en-2-YL)CYCLOHEX-3-en-1-ol AS ANTIPARKINSONIAN AGENT | 2023 |
|
RU2812081C1 |
| 2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
| 2-METHOXY-4[(3aR,7aS)-3,3,6-TRIMETHYL-1,3,3a,4,5,7a-HEXAHYDRO-2-BENZOFURAN-1-YL]PHENOL - NOVEL AGENT FOR TREATING PARKINSON'S DISEASE | 2010 |
|
RU2436782C1 |
| AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
| ANTICONVULSIVE MEDICATION | 2007 |
|
RU2355390C1 |
| INJECTABLE DOSAGE FORM FOR TREATMENT OF PARKINSON'S DISEASE, METHOD FOR PREPARING AND USING IT | 2011 |
|
RU2520758C2 |
| APPLICATION OF 2-HYDROXY-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-3-ENONE AS ANALGESIC | 2010 |
|
RU2421213C1 |
| 3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1,2-DIOL AS ANALGESIC AGENT | 2009 |
|
RU2409351C1 |
| ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
